251 related articles for article (PubMed ID: 33754011)
1. UXT antisense RNA 1 sever as a novel prognostic long non-coding RNA in early stage pancreatic ductal adenocarcinoma patients after receiving pancreaticoduodenectomy.
Liao X; Huang R; Wang X; Huang K; Yang C; Zhou X; Han C; Su H; Ye X; Liu K; Zhu G; Peng T
J Cancer; 2021; 12(7):2122-2139. PubMed ID: 33754011
[No Abstract] [Full Text] [Related]
2. Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma.
Liu XG; Xu H; Chen M; Tan XY; Chen XF; Yang YG; Lin MZ; Liu GH; Liang XL; Qian YB; Yuan GJ; Chen MQ; Li WT; Miao HL; Li MY; Liao XW; Dai W; Chen NP
Cancer Med; 2020 Mar; 9(6):2062-2076. PubMed ID: 31991068
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive investigation of the prognostic values and molecular mechanisms of syntaxin binding protein 5 antisense RNA 1 in patients with colon adenocarcinoma based on RNA sequencing dataset.
Wei H; Tang L; Wang J; Ni M; Liao X; Guo E
J Cancer; 2023; 14(9):1607-1622. PubMed ID: 37325053
[No Abstract] [Full Text] [Related]
4. Genome-wide RNA-sequencing dataset reveals the prognostic value and potential molecular mechanisms of lncRNA in non-homologous end joining pathway 1 in early stage Pancreatic Ductal Adenocarcinoma.
Shang LM; Liao XW; Zhu GZ; Huang KT; Han CY; Yang CK; Wang XK; Zhou X; Su H; Ye XP; Peng T
J Cancer; 2020; 11(19):5556-5567. PubMed ID: 32913451
[No Abstract] [Full Text] [Related]
5. Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy.
Liao X; Han C; Wang X; Huang K; Yu T; Yang C; Huang R; Liu Z; Han Q; Peng T
Cancer Manag Res; 2018; 10():3255-3271. PubMed ID: 30233242
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms.
Liu JQ; Liao XW; Wang XK; Yang CK; Zhou X; Liu ZQ; Han QF; Fu TH; Zhu GZ; Han CY; Su H; Huang JL; Ruan GT; Yan L; Ye XP; Peng T
BMC Gastroenterol; 2020 Dec; 20(1):415. PubMed ID: 33302876
[TBL] [Abstract][Full Text] [Related]
7. Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.
Liao X; Wang X; Huang K; Yang C; Yu T; Han C; Zhu G; Su H; Huang R; Peng T
Cancer Manag Res; 2018; 10():2537-2551. PubMed ID: 30127641
[TBL] [Abstract][Full Text] [Related]
8. Expression level of long non-coding RNA colon adenocarcinoma hypermethylated serves as a novel prognostic biomarker in patients with thyroid carcinoma.
Xiao Y; Tu Y; Li Y
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33792624
[TBL] [Abstract][Full Text] [Related]
9. Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.
Liao X; Huang K; Huang R; Liu X; Han C; Yu L; Yu T; Yang C; Wang X; Peng T
Onco Targets Ther; 2017; 10():4493-4506. PubMed ID: 28979141
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome related gene signature predicts the prognosis of patients with pancreatic ductal carcinoma. A novel link between metabolic dysregulation and pancreatic ductal carcinoma.
Cai W; Bao W; Chen S; Yang Y; Li Y
Cancer Cell Int; 2021 Dec; 21(1):698. PubMed ID: 34930261
[TBL] [Abstract][Full Text] [Related]
11. Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients.
Zhang D; Wang M; Peng L; Yang X; Li K; Yin H; Xia C; Cui F; Huang H; Jin Z
J Oncol; 2021; 2021():4986227. PubMed ID: 34987579
[TBL] [Abstract][Full Text] [Related]
12. Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal Adenocarcinoma.
Song W; He X; Gong P; Yang Y; Huang S; Zeng Y; Wei L; Zhang J
Front Genet; 2021; 12():639246. PubMed ID: 34249078
[No Abstract] [Full Text] [Related]
13. Analysis of long non-coding RNA expression profiles in pancreatic ductal adenocarcinoma.
Fu XL; Liu DJ; Yan TT; Yang JY; Yang MW; Li J; Huo YM; Liu W; Zhang JF; Hong J; Hua R; Chen HY; Sun YW
Sci Rep; 2016 Sep; 6():33535. PubMed ID: 27628540
[TBL] [Abstract][Full Text] [Related]
14. Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma.
Song J; Xu Q; Zhang H; Yin X; Zhu C; Zhao K; Zhu J
J Cell Biochem; 2018 Jun; 119(6):4559-4569. PubMed ID: 29239017
[TBL] [Abstract][Full Text] [Related]
15. UXT-AS1-induced alternative splicing of UXT is associated with tumor progression in colorectal cancer.
Yin J; Luo W; Zeng X; Zeng L; Li Z; Deng X; Tan X; Hu W
Am J Cancer Res; 2017; 7(3):462-472. PubMed ID: 28401004
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of ASPM, BUB1B and SPDL1 in tumor tissues predicts poor survival in patients with pancreatic ductal adenocarcinoma.
Tian X; Wang N
Oncol Lett; 2020 Apr; 19(4):3307-3315. PubMed ID: 32218868
[TBL] [Abstract][Full Text] [Related]
17. High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma.
Ye Y; Chen J; Zhou Y; Fu Z; Zhou Q; Wang Y; Gao W; Zheng S; Zhao X; Chen T; Chen R
J Transl Med; 2015 Apr; 13():137. PubMed ID: 25925763
[TBL] [Abstract][Full Text] [Related]
18. Integrated transcriptome meta-analysis of pancreatic ductal adenocarcinoma and matched adjacent pancreatic tissues.
Atay S
PeerJ; 2020; 8():e10141. PubMed ID: 33194391
[TBL] [Abstract][Full Text] [Related]
19. LncRNA co-expression network analysis reveals novel biomarkers for pancreatic cancer.
Giulietti M; Righetti A; Principato G; Piva F
Carcinogenesis; 2018 Jul; 39(8):1016-1025. PubMed ID: 29796634
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of Kinesin-4 family genes mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy.
Han Q; Han C; Liao X; Huang K; Wang X; Yu T; Yang C; Li G; Han B; Zhu G; Liu Z; Zhou X; Liu J; Su H; Shang L; Peng T; Ye X
Cancer Med; 2019 Nov; 8(15):6487-6502. PubMed ID: 31489986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
